E. Kirk Neely

Publication Details

  • BONE-MINERAL DENSITY DURING TREATMENT OF CENTRAL PRECOCIOUS PUBERTY JOURNAL OF PEDIATRICS Neely, E. K., Bachrach, L. K., Hintz, R. L., Habiby, R. L., Slemenda, C. W., FEEZLE, L., Pescovitz, O. H. 1995; 127 (5): 819-822


    Treatment of adults with gonadotropin releasing hormone analogs has resulted in rapid loss in bone mineral density (BMD). We measured lumbar and femoral neck BMD by dual-energy x-ray absorptiometry during 2 years of depot leuprolide therapy in 13 girls (mean age, 7.5 years; mean bone age, 10.9 years). At baseline, BMD was elevated for age and concordant with the advanced skeletal age. During therapy with gonadotropin releasing hormone analog, BMD values increased and BMD standard deviation scores for age and skeletal age did not change.

    View details for Web of Science ID A1995TD93100031

    View details for PubMedID 7472845

Stanford Medicine Resources:

Footer Links: